Arch Therapeutics Inc (ARTH)

[tjguy]

Successful human trials and EU approval are not baby steps, but there is still a LONG way to go after that. Money will still be needed, although hopefully it can be raised at higher prices.

The human trials have only been for external use so while that is great, what we really need is a trial for internal use which I think will come. They spoke of beginning a new trial in the second half of this year once they get the CE mark.

If successful, the label on the product could be changed and expanded for a wider variety of uses. That is when we will see real appreciation, but there should be hype leading up to that just as there has been good appreciation leading into this announcement.

FDA approval will also be big. So lots of catalysts to come over the next year and I expect to see more and more people jumping into this stock and accumulating over time.

Not sure when the institutions might jump in, but that would be huge. Perhaps we need an uplisting for that to happen and I think that too is in the plans once we meet the conditions. But I would think that would be at least a year away.

I have no guesses on stock price, but am hopeful for a $300 million market cap within 18 months which would mean about $2.50 per share(less fully diluted). I might be way off - in fact, I wouldn't put too much credibility to that guess at all. I did hear though at some point that Norchi had mentioned a $300 million market cap for the stock which is where I came up with that figure.